1-2 of 2
Keywords: Fatigue syndrome
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Donor Outcomes after Pure Laparoscopic versus Open Living Donor Nephrectomy: Focus on Pregnancy Rates, Hypertension and Quality of Life

Available to Purchase
Subject Area:
Further Areas
Frank Friedersdorff, Lisa Kothmann, Philipp Manus, Jan Roigas, Carsten Kempkensteffen, Ahmed Magheli, Jonas Busch, Lutz Liefeldt, Markus Giessing, Serdar Deger, Martin Schostak, Kurt Miller, Tom Florian Fuller
Journal: Urologia Internationalis
Urol Int (2016) 97 (4): 450–456.
https://doi.org/10.1159/000447064
Published Online: 01 December 2016
... the possible long-term side effects for donors who undergo a nephrectomy, the most prominent ones are arterial hypertension, chronic renal failure and chronic fatigue syndrome (CFS). CFS is a condition exhibiting symptoms of exhaustion, which are associated and also observed with chronic cardiovascular disease...
View article titled, Long-Term Donor Outcomes after Pure Laparoscopic versus Open Living Donor Nephrectomy: Focus on Pregnancy Rates, Hypertension and Quality of Life
Open the PDF for Long-Term Donor Outcomes after Pure Laparoscopic versus Open Living Donor Nephrectomy: Focus on Pregnancy Rates, Hypertension and Quality of Life in another window
Journal Articles

Prevalence of Late-Onset Hypogonadism in Men with Localized and Metastatic Renal Cell Carcinoma

Available to Purchase
Subject Area:
Further Areas
Bernhard Ralla, Ahmed Magheli, Ingmar Wolff, Barbara Erber, Irena Goranova, Frank Friedersdorff, Stefan Hinz, Carsten Kempkensteffen, Kurt Miller, Jonas Busch
Journal: Urologia Internationalis
Urol Int (2017) 98 (2): 191–197.
https://doi.org/10.1159/000450652
Published Online: 13 October 2016
.... Metastasis Hypogonadism Testosterone deficiency Fatigue syndrome Metastatic renal cell carcinoma Targeted therapy Renal cell carcinoma (RCC) accounts for 2-3% of adult malignancies and is the third most common urologic tumor in the European Union [ 1,2 ]. For localized, early-stage tumors...
View article titled, Prevalence of Late-Onset Hypogonadism in Men with Localized and Metastatic Renal Cell Carcinoma
Open the PDF for Prevalence of Late-Onset Hypogonadism in Men with Localized and Metastatic Renal Cell Carcinoma in another window